Dr. Alvaro González-Cantero, MD, PhD, works as a dermatologist at the Department of Dermatology of the Ramón y Cajal University Hospital in Madrid, Spain, where he combines patient care with research. He received his PhD in psoriasis and comorbidities in 2019. He is the principal investigator for a cohort study investigating the pathophysiological mechanisms underlying cardiovascular comorbidity in psoriasis. Dr. Gonzálo-Cantero has received independent and competitive research funding as principal investigator from the National Psoriasis Foundation (NPF) and the Spanish government. He has published extensively on the link between inflammation, atherosclerosis, and metabolic diseases in prestigious journals such as the Journal of Investigative Dermatology, Lancet, and the European Journal of Preventive Cardiology, among others. He has lectured on psoriasis at international meetings (AAD, EADV, SID). Dr. Gonzalez-Cantero has received numerous local and national awards and honors, including being named the best specialist in Spain. He is actively involved in several foundations and organizations in membership and leadership capacities, including the International Psoriasis Council (IPC), the Psoriasis Task Force of the EADV, and the National Psoriasis Foundation. He also serves as a reviewer for several international grant organizations and biomedical journals.
Areas of Interest
Psoriasis and comorbidities; the impact of psoriasis treatments on comorbidities; early intervention in psoriasis; psoriasis and lifestyle; mechanistic studies in psoriasis.